News
ImmPACT Bio Closes $111 Million Series B Financing, Names New Board Chair and New President and CEO, and Updates on Phase 1 Clinical Study in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Read full storyIterative Scopes Announces $150 Million Series B to Advance AI-Driven Precision Medicine for Gastroenterology
Read full storyPartner news
Leyden Labs Licenses Pan-Influenza Antibody from Janssen
Read full storyPartner news
The UK’s largest ever health research programme to transform the prevention, detection and treatment of diseases
Read full storyDigital Health Leader Verana Health Secures $150M Series E Funding Round
Read full storyPartner news
TRexBio Announces Collaboration with Janssen to Discover Novel Targets for Immunology and Inflammation
Read full storyPartner news
i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules
Read full storyPartner news
SRI International announces collaboration agreement with Janssen
Read full storyPartner news